Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Q: What does CUSIP 501976104 represent in this 13F holders report?

CUSIP 501976104 is the security identifier for KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in Q2 2025?

77 institutional investors reported KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 501976104

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 23,200,134
Total 13F value: $71,227,727
Share change: -2,558,806
Put/Call ratio: 0%
SEC-reported price per share: $3.07
Number of holders: 77
Value change: -$5,373,744
Number of buys: 44
Number of sells: 47
Shares outstanding: 56,833,213

Security key

501976104

Report period

Q2 2025

Institutions

Top holders

KYTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Kyverna Therapeutics, Inc. SEC filings Kyverna Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 501976104

Newer quarter: Q3 2025 Previous quarter: Q1 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Vida Ventures Advisors, LLC

Disclosed value leader

Vida Ventures Advisors, LLC

Comparable rows

15/15

Latest evidence

31 Mar 2025

13F 3/4/5 Lead comparable stake: 8% Showing 1-6 of 15 holder rows.

Quick read

Vida Ventures Advisors, LLC leads the comparable SEC ownership view at 8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vida Ventures Advisors, LLC's linked filing trail.

Comparable ownership Top 5

Vida Ventures Advisors, LLC 8%

GILEAD SCIENCES, INC. 7.3%

Bain Capital Life Sciences Invest... 5.9%

Novo Holdings A/S 3.3%

BlackRock, Inc. 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Vida Ventures Advisors, LLC	13F Company 13F	8%	$8,731,173 4,523,924 shares	—	31 Mar 2025
GILEAD SCIENCES, INC.	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	7.3%	$7,963,410 4,126,119 shares	—	31 Mar 2025
Bain Capital Life Sciences Investors, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	5.9%	$6,500,954 3,368,370 shares	—	31 Mar 2025
Novo Holdings A/S	13F Company 13F	3.3%	$3,570,500 1,850,000 shares	—	31 Mar 2025
BlackRock, Inc.	13F Company 13F	2.9%	$3,235,198 1,676,268 shares	—	31 Mar 2025
VANGUARD GROUP INC	13F Company 13F	2.3%	$2,506,007 1,298,449 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

23,200,134

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

-9

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend